newsfilter
← Latest News
GlobeNewswire·

X4 Pharmaceuticals Announces Proposed Underwritten Public Offering

BOSTON, Oct. 23, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (NASDAQ:XFOR) ("X4" or the "Company"), a company driven to improve the lives of people with rare hematology diseases, today announced that it has commenced